Clf Medical Technology Acceleration Program Inc is categorized under Organizations in Clifton Park, NY and active since 2011.
Clf Medical Technology Acceleration Program Inc was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Organizations business, which does work in the BOTH market, and is classified as a Organizations, under code number 813410 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 747 Pierce Road, Clifton Park, New York NY 12065 or by phoning (614) 882-4966. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clf Medical Technology Acceleration Program Inc |
| Address: | 747 Pierce Road, Clifton Park, New York 12065 |
| Phone Number: | (614) 882-4966 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Organizations |
| SIC Code: | 8699 |
| NAICS Code: | 813410 |
| Share This Business: |
Clf Medical Technology Acceleration Program Inc was started in 2011 to provide professional Organizations under the SIC code 8699 and NAICS code 813410. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact for inquiries that concern Clf Medical Technology Acceleration Program Inc by calling the company number (614) 882-4966, as your correspondence is most welcome. Additionally, the physical location of the single location of Clf Medical Technology Acceleration Program Inc can be found at the coordinates 42.897028,-73.787281 as well as the street address 747 Pierce Road in Clifton Park, New York 12065.
For its online presence, you may visit Clf Medical Technology Acceleration Program Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.